HHS (U.S. Department of Health and Human Services). 2010. The 2010 National Vaccine Plan, protecting the nation’s health through immunization. http://www.hhs.gov/nvpo/vacc_plan/2010%20Plan/nationalvaccineplan.pdf (accessed May 31, 2013).

IOM (Institute of Medicine). 1985. New vaccine development: Establishing priorities. Volume I, diseases of importance in the United States. Washington, DC: National Academy Press.

IOM. 1986. New vaccine development: Establishing priorities. Volume II, Diseases of importance in developing countries. Washington, DC: National Academy Press.

IOM. 2000. Vaccines for the 21st century: A tool for decisionmaking. Washington, DC: National Academy Press.

IOM. 2012. Ranking Vaccines: A prioritization framework: Phase I: Demonstration of concept and a software blueprint. Washington, DC: The National Academies Press.

Keeney, R., and H. Raiffa. 1976. Decisions with multiple objectives: Preferences and value tradeoffs. New York: John Wiley & Sons.

Milstien, J., and B. Candries. 2002. Economics of vaccine development and implementation: Changes over the past 20 years. Bethesda, MD: U.S. Department of Health and Human Services, National Institute of Health, National Institute of Allergy and Infectious Diseases.

Rappuoli, R., and A. Alderem. 2011. A 2020 vision for vaccines against HIV, tuberculosis and malaria. Nature 473(7348):463–469.

Rappuoli, R., S. Black, and P. H. Lambert. 2011. Vaccine discovery and translation of new vaccine technology. Lancet 378(9788):360–368.

Tomori, O. 2011. From smallpox eradication to the future of global health: Innovations, application and lessons for future eradication and control initiatives. Vaccine 29(Suppl. 4):D145–D148.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement